These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27693002)

  • 1. The role of miRNAs in cardiovascular disease risk factors.
    Jones Buie JN; Goodwin AJ; Cook JA; Halushka PV; Fan H
    Atherosclerosis; 2016 Nov; 254():271-281. PubMed ID: 27693002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology and pathogenesis of arteriosclerosis].
    Schettler G; Mörl H
    Naturwissenschaften; 1978 Mar; 65(3):130-6. PubMed ID: 205805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment.
    Economou EK; Oikonomou E; Siasos G; Papageorgiou N; Tsalamandris S; Mourouzis K; Papaioanou S; Tousoulis D
    Atherosclerosis; 2015 Aug; 241(2):624-33. PubMed ID: 26117399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein carriers of microRNAs.
    Michell DL; Vickers KC
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt B):2069-2074. PubMed ID: 26825691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-RNAs and High-Density Lipoprotein Metabolism.
    Canfrán-Duque A; Lin CS; Goedeke L; Suárez Y; Fernández-Hernando C
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1076-84. PubMed ID: 27079881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.
    Tijsen AJ; Pinto YM; Creemers EE
    Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1085-95. PubMed ID: 22942181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoproteins and atherosclerosis.
    Rader DJ
    Am J Cardiol; 2002 Oct; 90(8A):62i-70i. PubMed ID: 12419482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.
    Dlouhá D; Hubáček JA
    Physiol Res; 2017 Apr; 66(Suppl 1):S21-S38. PubMed ID: 28379027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs and High-Density Lipoprotein metabolism.
    Baldán Á; de Aguiar Vallim TQ
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt B):2053-2061. PubMed ID: 26869447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol and atherosclerosis: a contemporary perspective.
    Kashyap ML
    Ann Acad Med Singap; 1997 Jul; 26(4):517-23. PubMed ID: 9395824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary atherogenic risk factors in women.
    Stangl V; Baumann G; Stangl K
    Eur Heart J; 2002 Nov; 23(22):1738-52. PubMed ID: 12419293
    [No Abstract]   [Full Text] [Related]  

  • 13. Consideration of serum cholesterol in risk factor profiling for all young individuals.
    Berenson GS; Srinivasan SR
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():1-9. PubMed ID: 12063769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNAs in endothelial cell pathophysiology.
    Staszel T; Zapała B; Polus A; Sadakierska-Chudy A; Kieć-Wilk B; Stępień E; Wybrańska I; Chojnacka M; Dembińska-Kieć A
    Pol Arch Med Wewn; 2011 Oct; 121(10):361-6. PubMed ID: 21946298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease.
    Gallo W; Esguerra JLS; Eliasson L; Melander O
    PLoS One; 2018; 13(11):e0206974. PubMed ID: 30408096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiovascular risk factors on coronary artery remodeling in patients with mild atherosclerosis.
    Britten MB; Zeiher AM; Schächinger V
    Coron Artery Dis; 2003 Sep; 14(6):415-22. PubMed ID: 12966261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.